IRIS
TERRACCIANO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.640
EU - Europa 1.452
AS - Asia 948
AF - Africa 81
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.600
IT - Italia 739
SG - Singapore 497
CN - Cina 259
NL - Olanda 194
VN - Vietnam 148
FI - Finlandia 98
DE - Germania 95
CI - Costa d'Avorio 80
IE - Irlanda 72
UA - Ucraina 70
GB - Regno Unito 62
SE - Svezia 45
CA - Canada 39
IN - India 25
RU - Federazione Russa 19
FR - Francia 12
DK - Danimarca 8
BE - Belgio 7
LT - Lituania 7
HK - Hong Kong 6
AT - Austria 5
ES - Italia 5
CH - Svizzera 3
CZ - Repubblica Ceca 3
IR - Iran 3
AR - Argentina 2
AU - Australia 2
ID - Indonesia 2
NP - Nepal 2
PH - Filippine 2
PK - Pakistan 2
SI - Slovenia 2
TR - Turchia 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
MA - Marocco 1
MT - Malta 1
Totale 5.128
Salva come PNG Salva come JPEG
Città #
Chandler 490
Singapore 429
Naples 251
Santa Clara 228
Ashburn 205
Amsterdam 182
Dong Ket 148
Millbury 97
Napoli 91
Beijing 76
Boston 76
Jacksonville 74
Des Moines 60
Princeton 60
Lawrence 58
Nanjing 50
Wilmington 48
Helsinki 38
Boardman 36
Ottawa 33
Woodbridge 22
Dearborn 21
Seattle 19
Washington 19
Nanchang 16
Hebei 15
Milan 15
Fairfield 14
Houston 13
Falls Church 12
Formia 12
Shenyang 12
Kronberg 11
Munich 11
Norwalk 11
Caserta 10
Changsha 10
Dublin 10
Oristano 10
Pune 10
Redwood City 10
Rome 10
Tianjin 10
Casamassima 9
Falkenstein 9
Jiaxing 9
Los Angeles 9
Dallas 8
Frankfurt am Main 8
Lappeenranta 7
Augusta 6
Berlin 6
Hong Kong 6
London 6
Marcianise 6
Salerno 6
Cologno Monzese 5
Guangzhou 5
Pozzuoli 5
Sciacca 5
Acerra 4
Alba 4
Cambridge 4
Cascina 4
Council Bluffs 4
Florence 4
Moscow 4
Toronto 4
Vienna 4
Wuhan 4
Abidjan 3
Brno 3
Brussels 3
Ercolano 3
Fisciano 3
Gesualdo 3
Indiana 3
Lanzhou 3
Lizzanello 3
Marigliano 3
Marijampolė 3
Menlo Park 3
Mumbai 3
New York 3
Nuremberg 3
Orange 3
Paderno Dugnano 3
Parma 3
Pescara 3
Phoenix 3
Salento 3
Serra San Bruno 3
Shanghai 3
Stradella 3
Turin 3
Ardabil 2
Aversa 2
Banjarmasin 2
Bern 2
Campi Bisenzio 2
Totale 3.273
Salva come PNG Salva come JPEG
Nome #
null 88
A MOUSE MODEL DEMONSTRATES A MULTIGENIC ORIGIN OF CONGENITAL HYPOTHYROIDISM 78
Laboratory medicine: health evaluation in elite athletes 77
System for the automated sanitization of containers for biological samples and its process of use 72
Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report 67
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40 61
Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report 61
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats 60
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 59
New approaches in the diagnostic procedure of malignant pleural effusions 59
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 58
Athlete's Passport: Prevention of Infections, Inflammations, Injuries and Cardiovascular Diseases 58
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 57
Acute Effects of Triiodothyronine on Endothelial Function in Human Subjects. 57
Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. 57
Analysis of glycoproteins in human colon cancers, normal tissues and in human colon carcinoma cells reactive with monoclonal antibody NCL-19-9 56
HNP-1 and HBD-1 as biomarkers for the immune systems of elite basketball athletes 56
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 55
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis 54
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 51
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 51
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA 51
alpha1 (I) collagen gene expression in quail epiphyseal chondrocytes 49
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 49
Sistema per la sanificazione automatizzata di contenitori per campioni biologici e suo procedimento di utilizzo 48
Cyclic AMP-dependent secretion of Ca 19-9 by LS 174T human colon carcinoma cells 48
alpha1(I) collagen gene expression in quail epiphyseal chondrocytes. 48
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content. 48
Colorimetric Test for Fast Detection of SARS-CoV-2 in Nasal and Throat Swabs 48
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 47
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 47
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. 46
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 46
INSULIN RESISTANCE (IR) AND PROSTATE CANCER (PCa): THE EFFECT OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY ON IR IN PATIENTS WITH A DIAGNOSIS OF PCa 45
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors 45
Biomarkers in localized prostate cancer 44
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine 44
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 43
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 43
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 43
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 43
Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors. 42
Childhood obesity: an overview of laboratory medicine, exercise and microbiome 42
Rhes is involved in strial function 41
Diagnostic value of carbohydrate antigens in supernatantsand sediments of pleural effusions 41
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 41
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 41
Beyond PSA: The Role of Prostate Health Index (phi) 41
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro 40
Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy 40
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 40
The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer 40
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 40
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 39
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 39
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 39
Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model 39
Circular RNAs: An emerging type of non-coding RNA and their potential implications in bladder cancer 38
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform 38
Peri-Prostatic Adipocyte-Released TGFβ Enhances Prostate Cancer Cell Motility by Upregulation of Connective Tissue Growth Factor 38
Plasmatic Sil 6r/il-6 Ratio As A Potential Predictor of High Gleason Sum At Radical Prostatectomy 37
Expression of Lewis carbohydrate antigen in human tumors. 37
Iodine status assessment in Campania (Italy) as determined by urinary iodine excretion. 37
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 37
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 37
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 37
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 37
Salvage radical prostatectomy after external beam radiation therapy: A systematic review of current approaches 36
New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer 36
Enhancement of vascular endothelial function by recombinant human thyrotropin 36
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 36
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 35
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 34
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions. 33
Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formation. 33
The emerging role of obesity, diet and lipid metabolism in prostate cancer 33
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 33
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 33
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 33
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 33
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 33
Alteraziioni genetiche ed epigenetiche di Prep1 nel diabete mellito. 32
Prostate health index and multiparametric mri: Partners in crime fighting overdiagnosis and overtreatment in prostate cancer 32
Cytokine signature and COVID-19 prediction models in the two waves of pandemics 32
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 31
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 31
Mean reticolocyte hemoglobin content index plays a key role to identify children who are carriers of β-thalassemia 31
Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue 31
A Combinatorial Neural Network Analysis Reveals a Synergistic Behaviour of Multiparametric Magnetic Resonance and Prostate Health Index in the Identification of Clinically Significant Prostate Cancer 31
Matrix metalloroteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions 30
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome. 30
Comparison of anti–hepatitis D virus (HDV) ETI-AB-DELTAK-2 assay and the novel LIAISON® XL MUREX anti-HDV assay in the diagnosis of HDV infection 30
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 30
COVID-19 vaccine mRNABNT162b2 elicits human antibody response in milk of breastfeeding women 30
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 30
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 29
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status 29
Identification of genes controlled by the Foxe 1 transcription factor 29
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 29
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 29
Totale 4.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020194 0 0 0 0 0 0 31 17 10 42 50 44
2020/2021501 12 14 32 23 36 52 26 10 68 27 35 166
2021/2022856 18 12 11 3 21 12 24 31 86 83 262 293
2022/20231.267 140 102 48 59 148 138 16 126 183 197 83 27
2023/20241.072 38 134 206 110 68 95 16 132 27 23 148 75
2024/20251.008 204 216 12 67 208 296 5 0 0 0 0 0
Totale 5.386